Marksans Pharma Limited headquartered in Mumbai (India) is a global pharmaceutical company. They are actively engaged in R&D and offer CRAMS to global pharmaceutical companies. They have established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices, and adhering to stringent regulatory compliances. Their plants are approved by the prestigious US FDA, UK MHRA, Australian TGA, and other foreign health authorities. Their R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development, and conducting stability studies. They have a team of over 50 experienced scientists specializing in formulation development and analytical development. They possess end-to-end capabilities – from lab-scale development to pilot scale-up and from commercializing the product for large-scale manufacturing to marketing globally.